MedinotecMDNC 24 Gross Margin % is 46.93% as of Feb. 2026, which is 11% below its 10-year median of 52.79. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.
Gross Margin % is calculated as gross profit divided by its revenue. Medinotec's Gross Profit for the
three
months ended in Feb. 2026 was $0.86 Mil. Medinotec's Revenue for the
three
months ended in Feb. 2026 was $1.82 Mil. Therefore, Medinotec's Gross Margin % for the quarter that ended in Feb. 2026 was 46.93%.
The historical rank and industry rank for Medinotec's Gross Margin % or its related term are showing as below:
MDNC'
s Gross Margin % Range Over the Past 10 Years
Min: 48.65 Med: 52.79 Max: 58.2
Current: 52.71
During the past 5 years, the highestGross Margin % of Medinotec was 58.20%. The lowest was 48.65%. And the median was 52.79%.
MDNC's Gross Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 51.985
vs MDNC: 52.71
Medinotec had a gross margin of 46.93% for the quarter that ended in Feb. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Medinotec was 0.00% per year.
Medinotec (OTCPK:MDNC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Medinotec had a gross margin of 46.93% for the quarter that ended in Feb. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Medinotec Gross Margin % Related Terms
Medinotec Gross Margin % Historical Data
* Premium members only.
The historical data trend for Medinotec's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDNC vs NVNO, APYX, RDGL: Gross Margin % Comparison
For the Medical Devices subindustry, Medinotec's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinotec Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medinotec's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Medinotec's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Medinotec (MDNC) has a Gross Margin % of 46.93% as of Feb. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Medinotec and its competitors. This is 11% below median its historical median of 52.79. Over the past decade, Medinotec's Gross Margin % has ranged from 48.65 to 58.20.
Is Medinotec's Gross Margin % too high?
Medinotec's current Gross Margin % of 46.93% is 11% below median its 10-year median of 52.79. Over the past 10 years, this metric has ranged from a low of 48.65 to a high of 58.20. The Medical Devices & Instruments industry median Gross Margin % is 51.99. Medinotec's value of 46.93% is 9.7% below this industry median. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medinotec's Gross Margin % compare to NVNO and APYX?
Medinotec's Gross Margin % of 46.93% can be compared against companies in the Medical Devices & Instruments industry. The industry median Gross Margin % is 51.99. Medinotec's value of 46.93% is 9.7% below this benchmark. Historically, Medinotec's own Gross Margin % has ranged from 48.65 to 58.20 over the past decade. While the company's 10-year median is 52.79 vs. the industry median of 51.99, Medinotec has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.99, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinotec's current Gross Margin % of 46.93% is 9.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Medinotec and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinotec's current Gross Margin % is 46.93%, which is 11% below median its own 10-year median of 52.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinotec stock overvalued right now?
Medinotec (MDNC) has a current Gross Margin % of 46.93%. The current Gross Margin % is 46.93%, which is 11% below median its 10-year median of 52.79 and 9.7% below the Medical Devices & Instruments industry median of 51.99. Medinotec's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Medinotec (MDNC), the current Gross Margin % is 46.93% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
24GF Score
Get the complete analysis for MDNC
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDNC has been successfully added to your 
